Curt Bradshaw - Net Worth and Insider Trading

Curt Bradshaw Net Worth

The estimated net worth of Curt Bradshaw is at least $0 dollars as of 2024-11-13. Curt Bradshaw is the Chief Scientific Officer of Arrowhead Pharmaceuticals Inc and owns about 0 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $0. Details can be seen in Curt Bradshaw's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Curt Bradshaw has not made any transactions after 2020-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Curt Bradshaw

To

Curt Bradshaw Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Curt Bradshaw owns 2 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) , and NeuBase Therapeutics Inc (NBSE) .

Click here to see the complete history of Curt Bradshaw’s form 4 insider trades.

Insider Ownership Summary of Curt Bradshaw

Ticker Comapny Transaction Date Type of Owner
ARWR Arrowhead Pharmaceuticals Inc 2020-11-20 Chief Scientific Officer
NBSE NeuBase Therapeutics Inc 2020-12-01 Chief Scientific Officer

Curt Bradshaw Latest Holdings Summary

Curt Bradshaw currently owns a total of 1 stock. Curt Bradshaw owns 0 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of November 20, 2020, with a value of $0.

Latest Holdings of Curt Bradshaw

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARWR Arrowhead Pharmaceuticals Inc 2020-11-20 0 21.51 0

Holding Weightings of Curt Bradshaw


Curt Bradshaw Form 4 Trading Tracker

According to the SEC Form 4 filings, Curt Bradshaw has made a total of 1 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 31,250 shares on November 20, 2020, which brought Curt Bradshaw around $2 Million.

Insider Trading History of Curt Bradshaw

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Curt Bradshaw Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Curt Bradshaw Ownership Network

Ownership Network List of Curt Bradshaw

No Data

Ownership Network Relation of Curt Bradshaw

Insider Network Chart

Curt Bradshaw Owned Company Details

What does Arrowhead Pharmaceuticals Inc do?

Who are the key executives at Arrowhead Pharmaceuticals Inc?

Curt Bradshaw is the Chief Scientific Officer of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include Chief Commercial Officer Tracie Oliver , other: Senior Vice President James C Hamilton , and CFO Kenneth Allen Myszkowski .

Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary

Over the past 18 months, Curt Bradshaw made no insider transaction in Arrowhead Pharmaceuticals Inc (ARWR). Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 161,544 shares made by Christopher Richard Anzalone , a net sale of 55,383 shares made by James C Hamilton , and a net sale of 71,104 shares made by Kenneth Allen Myszkowski .

In summary, during the past 3 months, insiders sold 0 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 385,678 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 382,678 shares.

Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arrowhead Pharmaceuticals Inc Insider Transactions

No Available Data

Curt Bradshaw Mailing Address

Above is the net worth, insider trading, and ownership report for Curt Bradshaw. You might contact Curt Bradshaw via mailing address: 177 E Colorado Blvd, Ste 700, Pasadena Ca 91105.